Clinical trials don’t just advance science; they also serve as in-the-moment treatment options for patients. iClusion is an impact company facilitating access to clinical trials for all stakeholders in the clinical stage of drug development.

Treatments of tomorrow need clinical trials and clinical trials need patients today. iClusion solves the problems of the 2 biggest bottlenecks in drug development Local Study Startup and Patient Recruitment by means of a professional platform named Trial Eye and a public service named Heyleys.

Unique about the iClusion services is that they have been designed from the viewpoint of the 2 most important stakeholders within clinical trials; the patient and their treating physician. If they have easy access to clinical trials and can participate, drug development can speed up. The Footprint iClusion wants to leave on this planet, is changing the lives of patients.

The professional Trial Eye platform connects study sponsors, study sites, physicians and their patients in a closed-loop ecosystem, providing a harmonized and standardized network infrastructure for local study startup and patient recruitment. Because clinical trials should always be an option! Public service Heyleys is committed to giving patients access to information on research with new drugs to discuss these extra treatment options with their own physician. Because research of today is tomorrow’s treatment!

Both the Trial Eye and Heyleys services serve as a new front office and single point of entry to clinical trials, with the ability to connect the dots.

High tech connections can be made to other digital services within Clinical Operations like EHR, EDC and other data carriers that can match patients directly to trials. Examples of these kind of partnerships can be found in the Partner section of this website (about us).

You now have the means to shift gears.

Benefits for all

Patients

Increased chances for better outcomes —
today and tomorrow.

Physician

More treatment options
Increased access to innovative drugs
Maintain patient relationships

Hospital

Transparency in clinical trials
Participation in more trials
Quality of Care

Authorities

Faster market authorizations within regulatory compliance

Pharmaceutical Industry

Shorter duration of trials
Shorter time to market

Vision

The iClusion vision is to continuously increase accessibility in clinical cancer studies for oncologists and their patients.

Mission statement

The iClusion mission is to provide easy, trusted and standardized access to clinical cancer studies for oncologists and their patients through a specially designed clinical study portal, speeding up clinical trial accrual and therefor the entire drug development process.